Back to search
Refractory Angina Pectoris
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Angina Pectoris trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Angina Pectoris trials you may qualify forTo demonstrate the safety and effectiveness of the Shockwave Reducer for treatment of patients with refractory angina pectoris treated with maximally tolerated…
REGENERATE-COBRA will examine whether autologous stem cell treatment can improve angina symptoms and quality of life for patients with refractory angina. Patien…
The goal of this project is to provide an improvement in wire performance to expedite crossing difficult lesions in the coronary vasculature.
This is a two-part study, comprised of an initial open-label run-in phase (Part 1) in a subset of 3 subjects to provide first data regarding safety, and feasibi…
To demonstrate the feasibility and efficacy of the CS Reducer for the treatment of patients with ischaemia and non-obstructed coronary arteries (INOCA) and coro…
The increasing number of coronary revascularization procedures, coupled with improvements in drug therapy, has significantly extended the lifespan of patients w…
The purpose of this study is to demonstrate substantial equivalence between Pression's Wave PRO System and a commercially available predicate ECP device to supp…
The purpose of this study is to collect long term data of the Reducer System in subjects with refractory angina pectoris.
Refractory angina due to advanced obstructive coronary artery disease (CAD) remains a major clinical problem with limited evidence-based treatment options. The…